Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 2.57
2.39 %
$ 275 M
Market Cap
-4.94
P/E
Price Target
Average
133.46%
Revenue Forecast
Estimate
10.73%
EBIT
Estimate
24.18%
Net Income
Estimate
22.35%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aclaris Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for ACRS of $6 , with forecasts ranging from
a
low of
$3 to a high of $8 .
ACRS Lowest Price Target
Wall Street Target
3 USD
16.73%
ACRS Average Price Target
Wall Street Target
6 USD
133.46%
ACRS Highest Price Target
Wall Street Target
8 USD
211.28%
REVENUE FORECAST
Revenue Forecast Chart ACRS
EBIT FORECAST
EBIT Forecast Chart ACRS
NET INCOME FORECAST
Net Income Chart ACRS